Jinhe Biotechnology CO., LTD. (SHE:002688)
6.28
+0.08 (1.29%)
Apr 29, 2025, 2:45 PM CST
Jinhe Biotechnology CO., LTD. Company Description
Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China. The company offers chlortetracycline feed grade, an antimicrobial drug for the inhibition and treatment of white dysentery, enteritis, pneumonia, typhoid, paratyphoid, cholera, etc. in poultry and livestock; and chlortetracycline hydrochloride for the inhibition and treatment of pullorum disease, typhoid, and swine enteritis, as well as bacterial diseases, including paratyphoid and cholera.
It also exports its products to the United States, South-east Asia, Latin America, Europe, etc. Jinhe Biotechnology CO., LTD.
was founded in 1990 and is based in Dalian, China.
Jinhe Biotechnology CO., LTD.
Country | China |
Founded | 1990 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,316 |
CEO | Changxian Xie |
Contact Details
Address: 1-7-2 Building 27 Dalian, Liaoning Province 116023 China | |
Website | jinhe.com.cn |
Stock Details
Ticker Symbol | 002688 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100001HK7 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Changxian Xie | GM and Director |
You Shan Niu | Financial Director |
Zhi Jun Wang | Deputy GM and Director |
Yueqing Wang | Deputy GM and Non-Independent Director |
Manman Lu | Board Secretary and Director |
Zhi Sheng Wang | Deputy General Manager |
Ying Chun Liu | Deputy General Manager |
Yingzhen Guan | Deputy General Manager |
Lihang Zhou | Chief Accounting Officer |